Tata chemicals has successfully completed the acquisition of Novabay Pte. Limited through its wholly owned subsidiary, marking a significant milestone in the company's expansion strategy. The transaction was finalized on March 19, 2026, following the fulfillment of all conditions precedent outlined in the Share Purchase Agreement.

Acquisition Details

Tata Chemicals International Pte. Limited (TCIPL), the wholly owned subsidiary of Tata Chemicals, completed the acquisition of 100% equity share capital of Novabay Pte. Limited. The completion represents the successful conclusion of the acquisition process that was initially announced to the stock exchanges on December 19, 2025.

Regulatory Compliance

The company has informed both the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) about the completion of this acquisition under Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed information regarding the acquisition, as required under Schedule III of the SEBI Listing Regulations, was previously disclosed in the company's intimation dated December 19, 2025.

The completion follows the reference to SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, ensuring full compliance with regulatory requirements. Company Secretary Jeraz E. Mahernosh signed the official communication to the stock exchanges, confirming the transaction's completion.

Corporate Structure Impact

With this acquisition, Novabay Pte. Limited becomes a fully owned entity within the Tata Chemicals group structure through TCIPL. The transaction strengthens the company's international presence and expands its operational capabilities through the Singapore-based subsidiary structure. The acquisition disclosure has been made available on the company's official website at www.tatachemicals.com for stakeholder reference.

Tata Chemicals Limited has announced a scheduled analyst meeting with Morgan Stanley Research, set to take place on March 23, 2026, in Mumbai. The company has formally notified both BSE Limited and National Stock Exchange of India Limited about this upcoming interaction as part of its regulatory compliance obligations.

Meeting Details and Format

The scheduled interaction will follow a one-on-one meeting format between the company representatives and Morgan Stanley Research analysts. The meeting is planned to be held in Mumbai, providing an opportunity for direct engagement between the institutional investor and the company's management team.

Regulatory Compliance and Disclosure

The notification has been made in accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates companies to inform stock exchanges about scheduled meetings with analysts and institutional investors to ensure transparency in corporate communications.

Tata Chemicals has specifically clarified that no unpublished price sensitive information will be shared during the meeting. This commitment aligns with SEBI guidelines that prevent selective disclosure of material information that could impact stock prices or investor decisions.

Schedule Flexibility and Conditions

The company has indicated that the meeting schedule remains subject to potential changes. Such modifications may occur due to exigencies on the part of the analyst, institutional investor, or the company itself. This standard disclaimer provides flexibility while maintaining transparency about potential scheduling adjustments.

The formal communication was signed by Jeraz E. Mahernosh, Company Secretary (FCS 7008), and submitted to both major stock exchanges where the company's shares are listed for trading.